A four-step process – what, where, whom, how – can identify supply chain options that allow manufacturers to diversify away ...

As November kicks off, the rare-earth market is back in the spotlight due to supply disruptions from Myanmar, with analysts noting on Sunday that a sustained rise in prices is expected.

From big pharmaceutical companies such as AstraZeneca to small biotechnology firms like Amicus Therapeutics of New Jersey, which is looking for a non-Chinese company to supply raw materials for ...

Google Maps is a prominent example. The product surpassed two billion monthly active users, CEO Sundar Pichai said on Tuesday during quarterly earnings where he touted investments in AI as “paying off ...

As Google Maps approaches 20 years next year, it’s fitting that its latest updates revolve around the next era of Google: the search giant’s Gemini AI technology. In a Halloween announcement ...

Google Maps is getting new features powered by Gemini, Google’s generative AI model. On Thursday the company announced incoming updates that will allow Google Maps users in the U.S. to tap into ...

Google Maps is rolling out an update that brings a number of integrated AI features to its location platforms, including Waze. Starting this week, the company's Gemini AI will be integrated into ...

Google Maps is getting new navigation features that should make inner-city driving a little easier. When enhanced navigation rolls out in November, the blue line on Google Maps will provide a ...

The Chinese firm will print and supply 300 million notes at a cost of $8.99 million. The updated map has strained India-Nepal relations since 2020.

"We think that OPEC+ could delay the increase in supply until end of March/beginning of April of 2025, given that demand will drop in Q1 2025 from Q4 2024 because of seasonal factors," said John ...

(AP Photo/Ahn Young-joon) SEOUL, South Korea (AP) — Samsung Electronics on Thursday reported progress on a major supply deal for artificial intelligence-focused chips, aiming to reassure investors ...

Dr. Robert Brooks explores why pharma must map its supply chains in emerging markets. In the last few years we have seen a whole raft of supply chain disruptions hit the pharmaceutical sector ...